Clinical Trial: First Time Use of SD-809 in Huntington Disease

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Randomized Double Blind, Placebo Controlled Study of SD-809 Extended Release for the Treatment of Chorea Associated With Huntington Disease

Brief Summary: The purpose of this study is to determine whether SD-809 ER tablets are effective in the treatment of chorea associated with Huntington's Disease.